Brain natriuretic peptide and cardiac autonomic function in type 2 diabetic patients
Received 4 March 2004; received in revised form 6 September 2004; accepted 16 August 2005. published online 21 November 2005.
Abstract
The present study tested the hypothesis that increased plasma brain natriuretic peptide (BNP) levels are related to cardiac autonomic dysfunction in type 2 diabetic patients. A total of 32 consecutive Japanese patients with type 2 diabetes were assigned to either a high-BNP (≥18pg/ml) group (n=12; age 57±13 years, mean±S.D.) or a normal-BNP (<18pg/ml) group (n=20; 59±10 years). No patient had any overt structural heart disease. Cardiac autonomic function was assessed by measurements of baroreflex sensitivity (BRS), heart rate variability (HRV) and cardiac 123I-metaiodobenzylguanidine (MIBG) scintigraphic findings. BRS was lower (p<0.005) in the high-BNP group than in the normal-BNP group. However, the components of HRV, and the early and delayed myocardial uptake of 123I-MIBG and percentage washout rate of 123I-MIBG were not significantly different between the groups. The plasma level of BNP negatively correlated with BRS (r=0.35, p=0.049). These findings suggest that increased plasma BNP levels were related to cardiac reflex parasympathetic dysfunction in our Japanese type 2 diabetic patients.